Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 27, 2021 at 07:12 am EDT
Share
Guangdong Biolight Meditech Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 242.726 million compared to CNY 222.377 million a year ago. Operating income was CNY 27.518 million compared to CNY 51.152 million a year ago. Net income was CNY 24.603 million compared to CNY 40.649 million a year ago. Basic earnings per share from continuing operations was CNY 0.1684 compared to CNY 0.2783 a year ago.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. 
